相关实验视频

Updated: Jun 29, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

转移导向疗法在膀癌中是否有作用?

Mohammad Abufaraj^1,2, Joud Al Karmi³, Adan Bdeir³

¹Department of Urology, Medical University of Vienna, Vienna, Austria.

Current opinion in urology

|April 8, 2024

概括

以转移为导向的治疗,包括手术和放射治疗,在转移性膀癌中显示出有前途,特别是在寡头转移性疾病中. 需要进一步的研究来确认益处,并优化与全身治疗的组合.

科学领域:

在瘤学瘤学.
尿道瘤学尿道瘤学
癌症治疗癌症治疗

背景情况:

转移性膀癌的治疗传统上依赖于全身疗法.
针对转移的局部疗法的作用仍然是积极研究的领域.
寡基质扩散性疾病代表了一个独特的临床场景,具有局部干预的潜力.

研究的目的:

对转移性膀癌转移导向治疗 (MDT) 的当前文献进行审查和批评.
评估转移切除术和转移导向放射治疗的疗效.
探索MDT在寡头转移性疾病的背景下的影响.

主要方法:

综合性文献审查和对现有研究的批判性分析.
对转移切除术,转移导向放射治疗和组合疗法数据的评估.
评估影响结果的因素,如转移性负担和绩效状态.

主要成果:

转移性膀癌中转移切除术的结果存在争议,在精选患者中发现了好处.
以转移为导向的放射治疗显示出局部控制的潜力,并在寡头转移性疾病中改善了生存率.
同时的全身疗法,包括免疫疗法,可能会提高MDT的有效性.

结论:

转移切除术是膀癌中可切除的转移性沉积物的有希望的选择.
转移导向放射治疗在小转移性膀癌中提供局部控制和生存益处.
进一步的前性研究对于验证发现和探索MDT与全身治疗,特别是免疫治疗的协同作用至关重要.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...